Winton Group’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-49,746
Closed -$74.1K 739
2024
Q3
$74.1K Buy
+49,746
New +$73.8K 0.01% 597
2024
Q1
Sell
-35,160
Closed -$53.1K 805
2023
Q4
$53.1K Buy
35,160
+48
+0.1% +$69 ﹤0.01% 724
2023
Q3
$56.2K Buy
35,112
+152
+0.4% +$277 ﹤0.01% 747
2023
Q2
$75.9K Buy
+34,960
New +$54.7K 0.01% 728
2021
Q3
Sell
-59,191
Closed -$240K 1442
2021
Q2
$240K Sell
59,191
-60,939
-51% -$239K 0.01% 1283
2021
Q1
$515K Buy
120,130
+56,039
+87% +$268K 0.03% 875
2020
Q4
$253K Buy
+64,091
New +$268K 0.02% 1109
2020
Q3
Sell
-71,791
Closed -$245K 1572
2020
Q2
$245K Buy
+71,791
New +$161K 0.01% 1323
2020
Q1
Sell
-165,022
Closed -$243K 1500
2019
Q4
$243K Buy
+165,022
New +$276K ﹤0.01% 1411

Other funds holding OPK

Winton Group's OPK Position: Q4 2024 in Review

Winton Group sold out of Opko Health (OPK) in Q4 2024, closing a stake of 49,746 shares — an estimated $74.1K sold.

Winton Group first reported a position in OPK in Q4 2019 and held it in 9 quarters. The position peaked at $515K in Q1 2021. 235 funds tracked by Wall St. Rank hold OPK as of Q4 2024.

  • Winton Group reported no remaining Opko Health position as of Q4 2024 after selling out during the quarter.
  • Winton Group sold 49,746 Opko Health shares in Q4 2024, an estimated $74.1K.
  • Winton Group first reported a position in Opko Health in Q4 2019 and held it in 9 quarters.
  • Winton Group's Opko Health position peaked at $515K in Q1 2021.
  • 235 funds tracked by Wall St. Rank held Opko Health as of Q4 2024.

Based on Winton Group's 13F filing for Q4 2024, filed 12 Feb 2025.